Literature DB >> 22571951

An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction.

M Zuidersma1, J Ormel, H J Conradi, P de Jonge.   

Abstract

BACKGROUND: Depression after myocardial infarction (MI) is associated with poor cardiovascular prognosis. There is some evidence that specifically depressive episodes that develop after the acute event are associated with poor cardiovascular prognosis. The aim of the present study was to evaluate whether an increase in the number of depressive symptoms after MI is associated with new cardiac events.
METHOD: In 442 depressed and 325 non-depressed MI patients the Composite International Diagnostic Interview interview to assess post-MI depression was extended to evaluate the presence of the ICD-10 depressive symptoms just before and after the MI. The effect of an increase in number of depressive symptoms during the year following MI on new cardiac events up to 2.5 years post-MI was assessed with Cox regression analyses.
RESULTS: Each additional increase of one symptom was significantly associated with a 15% increased risk of new cardiac events, and this was stronger for non-depressed than for depressed patients. This association was independent of baseline cardiac disease severity. There was no interaction with the number of depressive symptoms pre-MI.
CONCLUSIONS: Our findings suggest that an increase in depressive symptoms after MI irrespective of the state of depression pre-MI explains why post-MI depression is associated with poor cardiovascular prognosis. Also increases in depressive symptoms after MI resulting in subthreshold depression should be evaluated as a prognostic marker. Whether potential mechanisms such as cardiac disease severity or inflammation underlie the association remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22571951     DOI: 10.1017/S0033291711001784

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  What does the beck depression inventory measure in myocardial infarction patients? a psychometric approach using item response theory and person-fit.

Authors:  Klaas J Wardenaar; Rob B K Wanders; Annelieke M Roest; Rob R Meijer; Peter De Jonge
Journal:  Int J Methods Psychiatr Res       Date:  2015-05-21       Impact factor: 4.035

2.  Genetic Moderators of the Impact of Physical Activity on Depressive Symptoms.

Authors:  V M Dotson; F C Hsu; T Y Langaee; C W McDonough; A C King; R A Cohen; A B Newman; S B Kritchevsky; V Myers; T M Manini; M Pahor
Journal:  J Frailty Aging       Date:  2016

3.  BRIGHTEN Heart: Design and baseline characteristics of a randomized controlled trial for minority older adults with depression and cardiometabolic syndrome.

Authors:  S K Rothschild; E E Emery-Tiburcio; L J Mack; Y Wang; E F Avery; H Li; R L Golden; L H Powell
Journal:  Contemp Clin Trials       Date:  2016-04-16       Impact factor: 2.226

4.  Symptomatic menopausal transition increases the risk of new-onset depressive disorder in later life: a nationwide prospective cohort study in Taiwan.

Authors:  Mu-Hong Chen; Tung-Ping Su; Cheng-Ta Li; Wen-Han Chang; Tzeng-Ji Chen; Ya-Mei Bai
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

Review 5.  Mental health and disability research priorities and capacity needs in Ghana: findings from a rapid review and research priority ranking survey.

Authors:  Benedict Weobong; Kenneth Ae-Ngibise; Grace Mwangi; Lionel Sakyi; Crick Lund
Journal:  Glob Health Action       Date:  2022-12-31       Impact factor: 2.996

6.  Depression as a risk factor for adverse outcomes in coronary heart disease.

Authors:  Kenneth E Freedland; Robert M Carney
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

7.  Depression as a non-causal variable risk marker in coronary heart disease.

Authors:  Anna Meijer; Marij Zuidersma; Peter de Jonge
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.